Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#151 / 200 Total
ENLV - Enlivex Therapeutics Ltd - Stock Price Chart
TickerENLV [NASD]
CompanyEnlivex Therapeutics Ltd
CountryIsrael
IndustryBiotechnology
Market Cap28.38MEPS (ttm)-1.40
P/E-EPS this Y48.08%
Forward P/E-EPS next Y27.16%
PEG-EPS past 5Y32.51%
P/S-EPS next 5Y-
P/B0.95EPS Q/Q43.28%
Dividend-Sales Q/Q-
Insider Own12.70%Inst Own2.21%
Insider Trans0.00%Inst Trans-12.09%
Short Float0.64%EarningsMay 24
Analyst Recom1.00Target Price6.00
Avg Volume72.37K52W Range1.15 - 4.59
Jul-23-24 08:00AM Enlivex Receives Regulatory Authorization For The Initiation Of A Phase I Clinical Trial To Evaluate Allocetra In Patients With Psoriatic Arthritis (GlobeNewswire) +5.11%
Jul-19-24 09:00AM Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
Jun-24-24 08:00AM Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis (GlobeNewswire)
Jun-20-24 08:00AM Join Enlivex Therapeutics' Chief Executive Officer for a Live Investor Webinar and Q&A Session on June 25 (GlobeNewswire)
Jun-17-24 08:00AM Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis (GlobeNewswire)
Jun-03-24 08:00AM Enlivex Receives Regulatory Authorization for the Initiation of a Placebo-Controlled Phase I/II Trial Evaluating Allocetra in Up To 46 Patients with Thumb Osteoarthritis (GlobeNewswire) +8.09%
May-29-24 04:15PM Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering (GlobeNewswire) -5.07%
May-28-24 08:12AM Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering (GlobeNewswire)
Apr-29-24 08:00AM Enlivex CEO Issues Letter to Shareholders Perspectives on Recent Events (GlobeNewswire) +15.28%
Apr-22-24 08:00AM Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis (GlobeNewswire)
NTRB - Nutriband Inc - Stock Price Chart
TickerNTRB [NASD]
CompanyNutriband Inc
CountryUSA
IndustryBiotechnology
Market Cap83.46MEPS (ttm)-0.77
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-5.27%
P/S41.32EPS next 5Y-
P/B6.20EPS Q/Q-59.88%
Dividend-Sales Q/Q-14.34%
Insider Own50.20%Inst Own2.29%
Insider Trans0.00%Inst Trans12.51%
Short Float0.98%Earnings-
Analyst Recom1.00Target Price18.00
Avg Volume36.35K52W Range1.53 - 9.60
Jul-19-24 07:00AM Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25 (ACCESSWIRE) +12.77%
Jul-15-24 07:00AM Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology (ACCESSWIRE)
Jun-25-24 06:52AM NTRB Stock Earnings: Nutriband Reported Results for Q1 2024 (InvestorPlace)
Jun-20-24 07:00AM Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl (ACCESSWIRE) +11.18%
Jun-03-24 07:00AM Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year (ACCESSWIRE) +13.03%
May-21-24 07:00AM Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30 (ACCESSWIRE)
May-16-24 07:00AM Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors (ACCESSWIRE) -6.53%
May-10-24 09:00AM Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
May-03-24 11:54AM NTRB Stock Earnings: Nutriband Reported Results for Q4 2023 (InvestorPlace)
Apr-25-24 07:00AM IBN Coverage Initiated for Nutriband Inc. (GlobeNewswire) -5.19%
VRPX - Virpax Pharmaceuticals Inc - Stock Price Chart
TickerVRPX [NASD]
CompanyVirpax Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap6.64MEPS (ttm)-14.42
P/E-EPS this Y71.01%
Forward P/E-EPS next Y54.79%
PEG-EPS past 5Y-20.69%
P/S-EPS next 5Y-
P/B-EPS Q/Q-111.83%
Dividend-Sales Q/Q-
Insider Own10.99%Inst Own0.03%
Insider Trans0.00%Inst Trans-5.18%
Short Float14.76%EarningsMay 13/a
Analyst Recom1.00Target Price3.00
Avg Volume6.05M52W Range0.46 - 9.50
Jul-24-24 07:30AM Virpax Regains Compliance with Nasdaq Minimum Bid Price (Business Wire)
Jul-10-24 12:08PM PLUG Stock: Plug Power Shares Hydrogen Refueling Station Update (InvestorPlace) +46.55%
11:45AM Why Is Virpax Pharmaceuticals (VRPX) Stock Up 98% Today? (InvestorPlace)
11:29AM Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why? (Benzinga)
07:30AM Virpax Announces Positive Results of Swine Model Pilot Study for Probudur (Business Wire)
Jul-08-24 12:36PM GRFS Stock Alert: Grifols Pops 20% on Takeover Interest (InvestorPlace) +92.04%
11:56AM Why Is Virpax Pharmaceuticals (VRPX) Stock Up 97% Today? (InvestorPlace)
07:30AM Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding (Business Wire)
Jun-18-24 07:37AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) -24.90%
May-29-24 07:30AM Virpax Pharmaceuticals to Present at 2024 BIO International Convention (Business Wire)
TNDM - Tandem Diabetes Care Inc - Stock Price Chart
TickerTNDM [NASD, RUT]
CompanyTandem Diabetes Care Inc
CountryUSA
IndustryMedical Devices
Market Cap2.59BEPS (ttm)-2.17
P/E-EPS this Y51.76%
Forward P/E-EPS next Y33.70%
PEG-EPS past 5Y-6.11%
P/S3.36EPS next 5Y-
P/B10.64EPS Q/Q65.92%
Dividend-Sales Q/Q13.16%
Insider Own0.80%Inst Own115.75%
Insider Trans-0.96%Inst Trans1.84%
Short Float17.12%EarningsAug 01/a
Analyst Recom1.89Target Price51.67
Avg Volume1.57M52W Range13.82 - 53.69
Today 09:37AM Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge? (The Wall Street Journal)
Jul-25-24 06:19PM Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research)
Jul-11-24 04:05PM Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024 (Business Wire)
Jul-10-24 06:29PM Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research)
Jul-01-24 04:24PM Tandem Diabetes (TNDM) Posts Positive Data for Tandem Mobi (Zacks)
Jun-24-24 08:38PM Analyst Report: Tandem Diabetes Care, Inc. (Morningstar Research) -6.68%
07:13AM Tandem showcases data from user survey of Tandem Mobi (Medical Device Network)
Jun-22-24 11:00AM Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions (Business Wire)
Jun-21-24 02:42AM Tandem names Jean-Claude Kyrillos as chief operating officer (MedTech Dive)
Jun-20-24 09:00AM Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer (Business Wire)
CBAT - CBAK Energy Technology Inc - Stock Price Chart
TickerCBAT [NASD]
CompanyCBAK Energy Technology Inc
CountryChina
IndustryElectrical Equipment & Parts
Market Cap125.02MEPS (ttm)0.10
P/E14.34EPS this Y1166.67%
Forward P/E3.76EPS next Y15.62%
PEG0.48EPS past 5Y17.82%
P/S0.57EPS next 5Y30.00%
P/B1.03EPS Q/Q803.87%
Dividend-Sales Q/Q38.74%
Insider Own20.32%Inst Own2.14%
Insider Trans0.00%Inst Trans-20.28%
Short Float1.50%EarningsMay 10/b
Analyst Recom-Target Price2.50
Avg Volume275.57K52W Range0.76 - 2.08
Jun-14-24 09:00AM CBAK Energy Secures Nearly USD7 Million Order From Renowned European Client (PR Newswire) +5.77%
Jun-04-24 09:00AM CBAK Energy Unveils Breakthrough in Fast-Charging Technology with Enhanced Model 32140 Battery, Achieving Full Charge in Just 35 Minutes (PR Newswire) -14.81%
May-12-24 08:33AM CBAK Energy Technology, Inc. (NASDAQ:CBAT) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 04:05PM CBAK Energy Technology Inc (CBAT) Reports Strong Q1 2024 Financial Results (GuruFocus.com) +5.26%
10:53AM CBAT Stock Earnings: CBAK Energy Tech Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:00AM CBAK Energy Reports First Quarter 2024 Unaudited Financial Results (PR Newswire)
May-03-24 06:00AM CBAK Energy to Report First Quarter 2024 Unaudited Financial Results on Friday, May 10, 2024 (PR Newswire)
Mar-16-24 09:41AM CBAK Energy Technology, Inc. (NASDAQ:CBAT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-15-24 07:31AM CBAK Energy Technology Inc (CBAT) Reports Mixed 2023 Financial Results (GuruFocus.com) -9.40%
06:09AM CBAK Energy Technology Posts Narrower Loss In Q4 (RTT News)
GNFT - Genfit ADR - Stock Price Chart
TickerGNFT [NASD]
CompanyGenfit ADR
CountryFrance
IndustryBiotechnology
Market Cap199.54MEPS (ttm)-0.63
P/E-EPS this Y155.69%
Forward P/E9.01EPS next Y27.32%
PEG-EPS past 5Y26.89%
P/S6.46EPS next 5Y-
P/B2.68EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own2.90%Inst Own0.15%
Insider Trans0.00%Inst Trans8.59%
Short Float0.13%EarningsMay 14/a
Analyst Recom1.00Target Price10.64
Avg Volume23.77K52W Range2.89 - 6.05
Today 07:45AM GENFIT: Positive Opinion from EMA Committee for Ipsens Iqirvo® (elafibranor) in Primary Biliary Cholangitis (GlobeNewswire) -11.28%
Jul-09-24 04:10PM GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial (GlobeNewswire)
Jun-17-24 04:10PM GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH (GlobeNewswire)
Jun-10-24 05:22PM GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsens Iqirvo® for Primary Biliary Cholangitis (GlobeNewswire) -6.59%
May-29-24 04:10PM GENFIT to Present Latest ACLF Research at EASL Congress 2024 (GlobeNewswire) +11.85% +14.07%
May-22-24 12:05PM GENFIT: May 22, 2024 Combined Shareholders Meeting Results (GlobeNewswire) +8.29%
May-14-24 04:10PM GENFIT Reports First Quarter 2024 Financial Information (GlobeNewswire)
Apr-25-24 04:10PM GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023) (GlobeNewswire)
Apr-15-24 04:10PM GENFIT Annual Combined General Meeting of May 22, 2024 Availability of Preparatory Documents (GlobeNewswire)
Apr-05-24 02:00PM GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report on Form 20-F (GlobeNewswire)
HUMA - Humacyte Inc - Stock Price Chart
TickerHUMA [NASD, RUT]
CompanyHumacyte Inc
CountryUSA
IndustryBiotechnology
Market Cap945.50MEPS (ttm)-1.01
P/E-EPS this Y7.26%
Forward P/E-EPS next Y15.89%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B36.16EPS Q/Q17.68%
Dividend-Sales Q/Q-
Insider Own22.76%Inst Own19.61%
Insider Trans-10.97%Inst Trans-9.29%
Short Float15.88%EarningsMay 10/b
Analyst Recom1.40Target Price9.30
Avg Volume3.13M52W Range1.96 - 9.97
Jul-16-24 08:00AM Humacyte Board of Directors Strengthened with Addition of John P. Bamforth and Keith Anthony Jones (GlobeNewswire)
Jul-09-24 10:07AM Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs (Business Wire)
Jul-01-24 08:00AM Humacyte Acellular Tissue Engineered Vessel (ATEV ) Receives FDA's Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD) (GlobeNewswire) +11.87%
Jun-25-24 08:00AM Humacyte Presents Positive Preclinical Data For Its BioVascular Pancreas (BVP ) Program (GlobeNewswire)
Jun-17-24 08:00AM Centers for Medicare & Medicaid Services (CMS) Issues ICD-10-PCS Codes for Humacyte's Human Acellular Vessel (HAV ) (GlobeNewswire) -12.20%
Jun-03-24 07:01PM Insider Sale: COO Heather Prichard Divests All Shares in Humacyte Inc (HUMA) (GuruFocus.com) -9.50%
May-30-24 08:00AM Humacyte to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +18.03%
May-16-24 02:20PM Hedge Fund and Insider Trading News: Michael Burry, Leon Cooperman, Ray Dalio, Stanley Druckenmiller, Millennium Management, Paulson & Co, Rokos Capital Management, Humacyte Inc (HUMA), GeneDx Holdings Corp. (WGS), and More (Insider Monkey)
May-13-24 08:00AM Humacyte to Participate at Upcoming Investor Conferences in May (GlobeNewswire) +16.60%
May-10-24 02:43PM Humacyte Inc (HUMA) Q1 2024 Earnings: Aligns with Analyst Projections Amid Strategic Advances (GuruFocus.com)
PHIO - Phio Pharmaceuticals Corp - Stock Price Chart
TickerPHIO [NASD]
CompanyPhio Pharmaceuticals Corp
CountryUSA
IndustryBiotechnology
Market Cap2.03MEPS (ttm)-32.31
P/E-EPS this Y65.00%
Forward P/E0.12EPS next Y307.69%
PEG-EPS past 5Y62.38%
P/S-EPS next 5Y-
P/B0.36EPS Q/Q85.09%
Dividend-Sales Q/Q-
Insider Own0.98%Inst Own3.28%
Insider Trans-Inst Trans-
Short Float1.16%EarningsMay 09/a
Analyst Recom1.00Target Price36.00
Avg Volume27.88K52W Range3.35 - 29.07
Jul-12-24 08:00AM Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds (Newsfile) -13.60%
Jul-08-24 08:00AM Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762 (Newsfile) +9.06%
Jul-05-24 08:00AM Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds (Newsfile)
Jul-02-24 11:45AM Phio Pharmaceuticals Announces Reverse Stock Split (Newsfile) -9.17%
Jun-18-24 07:30AM Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging (Newsfile)
May-28-24 07:30AM Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762 (Newsfile)
May-23-24 05:00PM Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) (Newsfile)
May-17-24 09:00AM Phio Pharmaceuticals Secures New Investor (GlobeNewswire) +7.44%
May-16-24 08:00AM Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID) (GlobeNewswire) -8.45%
May-15-24 01:00PM Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation Study (GlobeNewswire) +9.02%
ENGN - enGene Holdings Inc - Stock Price Chart
TickerENGN [NASD]
CompanyenGene Holdings Inc
CountryCanada
IndustryBiotechnology
Market Cap397.44MEPS (ttm)-5.36
P/E-EPS this Y98.98%
Forward P/E-EPS next Y-9.09%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.64EPS Q/Q-12154.84%
Dividend-Sales Q/Q-
Insider Own72.00%Inst Own33.23%
Insider Trans-0.16%Inst Trans1.29%
Short Float1.39%EarningsJun 14/b
Analyst Recom1.00Target Price32.50
Avg Volume123.04K52W Range6.69 - 47.17
Jul-24-24 04:05PM enGene Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
06:30AM enGene Announces Appointment of Ron Cooper as Chief Executive Officer (Business Wire)
Jul-18-24 08:00AM NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors (GlobeNewswire)
Jun-14-24 07:01AM enGene Reports Second Quarter 2024 Financial Results and Provides a Business Update (Business Wire) -10.00%
May-29-24 07:30AM enGene to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-15-24 04:05PM enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors (Business Wire)
May-02-24 04:05PM enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting (PR Newswire)
Apr-09-24 08:56AM /C O R R E C T I O N -- enGene Inc./ (PR Newswire)
08:00AM engender Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development (PR Newswire)
Mar-11-24 05:16PM enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress (PR Newswire)
MXL - MaxLinear Inc - Stock Price Chart
TickerMXL [NASD, RUT]
CompanyMaxLinear Inc
CountryUSA
IndustrySemiconductors
Market Cap1.06BEPS (ttm)-2.31
P/E-EPS this Y-176.36%
Forward P/E27.77EPS next Y154.76%
PEG-EPS past 5Y-18.83%
P/S2.37EPS next 5Y14.14%
P/B1.74EPS Q/Q-769.50%
Dividend-Sales Q/Q-49.99%
Insider Own8.31%Inst Own85.06%
Insider Trans-0.17%Inst Trans-0.37%
Short Float4.95%EarningsJul 24/a
Analyst Recom2.09Target Price22.33
Avg Volume825.71K52W Range13.43 - 35.00
Jul-25-24 11:14AM Q2 2024 Maxlinear Inc Earnings Call (Thomson Reuters StreetEvents) -37.10%
Jul-24-24 05:30PM MaxLinear (MXL) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -5.11%
04:27PM MaxLinear: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM MaxLinear, Inc. Announces Second Quarter 2024 Financial Results (Business Wire)
Jul-02-24 04:35PM MaxLinear, Inc. Announces Conference Call to Review Second Quarter 2024 Financial Results (Business Wire)
Jun-24-24 10:57PM MaxLinear, Inc. (MXL): Is this Semiconductor Stock Still a Good Buy Despite Decreased Revenue in Q1? (Insider Monkey)
09:09PM 10 Small Publicly Traded Semiconductor Companies To Buy (Insider Monkey)
12:22PM MaxLinear (MXL) Surges 5.9%: Is This an Indication of Further Gains? (Zacks)
Jun-17-24 04:35PM MaxLinear Announces New Employee Inducement Grants (Business Wire)
Jun-11-24 06:40AM Exit Now! 3 Nasdaq Stocks to Sell in June 2024 (InvestorPlace)
1⋯1011121314151617181920
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.